Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

CIRCULATION

卷 142, 期 17, 页码 1687-1690

LIPPINCOTT WILLIAMS & WILKINS

axicabtagene ciloleucel; chimeric antigen receptor T-cell therapy; cardiomyopathy; cardiotoxicity; cytokine release syndrome; heart failure; lymphoma; non-Hodgkin; receptors; chimeric antigen; tisagenlecleucel

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

1. Gelb Master Clinician Award